Potential Utility of Retinal Imaging for Alzheimer’s Disease: A Review
Open Access
- 22 June 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 10, 188
Abstract
The ensuing upward shift in demographic distribution due to the increase in life expectancy has resulted in a rising prevalence of Alzheimer’s disease (AD). The heavy public burden of AD, along with the urgent to prevent and treat the disease before the irreversible damage to the brain, calls for a sensitive and specific screening technology to identify high-risk individuals before cognitive symptoms arise. Even though current modalities, such as positron emission tomography (PET) and cerebrospinal fluid (CSF) biomarker, showed their potential clinical uses in early detection of AD, the high cost, narrow isotope availability of PET probes and invasive characteristics of CSF biomarker limited their broad utility. Therefore, additional tools for detection of AD are needed. As a projection of the central nervous system (CNS), the retina has been described as a “window to the brain” and a novel marker for AD. Low cost, easy accessibility and non-invasive features make retina tests suitable for large-scale population screening and investigations of preclinical AD. Furthermore, a number of novel approaches in retina imaging, such as optical coherence tomography (OCT), have been developed and made it possible to visualize changes in the retina at a very fine resolution. In this review, we outline the background for AD to accelerate the adoption of retina imaging for the diagnosis and management of AD in clinical practice. Then, we focus on recent findings on the application of retina imaging to investigate AD and provide suggestions for future research directions.Keywords
This publication has 151 references indexed in Scilit:
- Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s diseaseTranslational Psychiatry, 2013
- β‐Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigmentEMBO Molecular Medicine, 2012
- Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse modelNeuroImage, 2011
- Multiphoton in vivo imaging of amyloid in animal models of Alzheimer’s diseaseNeuropharmacology, 2010
- Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer’s diseaseDocumenta Ophthalmologica, 2010
- Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivoCell Death & Disease, 2010
- Detection of Macular Ganglion Cell Loss in Glaucoma by Fourier-Domain Optical Coherence TomographyOphthalmology, 2009
- Design, Synthesis, and Testing of Difluoroboron-Derivatized Curcumins as Near-Infrared Probes for in Vivo Detection of Amyloid-β DepositsJournal of the American Chemical Society, 2009
- Photoreceptor Layer Thinning over Drusen in Eyes with Age-Related Macular Degeneration Imaged In Vivo with Spectral-Domain Optical Coherence TomographyOphthalmology, 2009
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s diseaseNature, 2008